HAP1, a new revolutionary cell model for gene editing using CRISPR-Cas9
The use of next-generation sequencing (NGS) technologies has been instrumental in the characterization of the mutational landscape of complex human diseases like cancer. But despite the enormous rise in the identification of disease candidate genetic variants, their functionality is yet to be fully...
Main Authors: | Gemma Llargués-Sistac, Laia Bonjoch, Sergi Castellvi-Bel |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2023.1111488/full |
Similar Items
-
CRISPR-Cas9 Germline Editing: Full Steam Ahead to Revolutionary Profit or Revolutionary Public Medicine?
by: Yuka Sai
Published: (2018-11-01) -
CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017-06-01) -
Optimizing CRISPR Cas9 Genome Editing System: A Review
by: Meen Bahadur Budhthoki, et al.
Published: (2017-03-01) -
Inducible Genome Editing with Conditional CRISPR/Cas9 Mice
by: Alexandra Katigbak, et al.
Published: (2018-05-01) -
Expanding CRISPR/Cas9 Genome Editing Capacity in Zebrafish Using SaCas9
by: Yan Feng, et al.
Published: (2016-08-01)